AMPHISTA

Updated 18 days ago
Private Limited Company
  • Active - 11119959 (CH)
  • Age: 6 years
  • ID: 47278455/20
The Cori Building, Granta Park, Great Abington, Cambridge CB21 6GQ
CLICK HERE TO SEE DETAILS OF COMPANY CHANGES
• 72110 - Research and experimental development on biotechnology
Amphista is the leading next generation TPD company, rapidly working to advance a portfolio of innovative therapeutic candidates from early stage discovery to clinical stage research and commercialization... Founded by Advent Life Sciences, Amphista is built on the groundbreaking science from the laboratory of Professor Alessio Ciulli, University of Dundee, a world leader in the field of targeted protein degradation. Alessio Ciulli is Chair of Chemical and Structural Biology at the School of Life Sciences, University of Dundee, and is Founder and Director of Dundee's new Centre for Targeted Protein Degradation (CeTPD)... Amphista is identifying and advancing novel approaches in targeted protein degradation (TPD) to develop a new generation of innovative therapies with significantly improved efficacy.
Also known as: Amphista Therapeutics, AMPHISTA THERAPEUTICS LIMITED
Registration numbers: 11119959 (CH)
Primary location: Cambridge United Kingdom
  • 0
  • 0
Interest Score
1
HIT Score
0.79
Chairman
Joshua Brumm
General
in..@amphista.com

UK Company Data

Company number
11119959		 Account category
SMALL		 Account ref. day
31		 Account ref. month
12
Accounts next due date
2024-09-30		 Accounts last made up date
2022-12-31		 Returns next due date
2019-01-17		 Returns last made up date
N/A
Num. mort. charges
2		 Num. mort. outstanding
1		 Num. mort. part. satisfied
0		 Num. mort. satisfied
1
Num. gen. partners
0		 Num. lim. partners
0
Domain
amphista.com
Actual
amphista.com
IP
104.248.174.66
Status
OK
Category
Company
0 comments Add a comment